Ruiqi Wang

3.2k citations
115 papers · 1.6k indexed · 1 hit paper · h-index 23
Topics
Allergic Rhinitis and Sensitization (11 papers)RNA modifications and cancer (10 papers)Cancer-related molecular mechanisms research (9 papers)

In The Last Decade

Ruiqi Wang

105 papers receiving 1.6k citations

Hit Papers

Cancer epigenetics: from laboratory studies and clinical ...2024202620252024255075100

Peers

Ruiqi Wang
Comparison fields: 5 of 138
  • Molecular Biology 920
  • Cancer Research 553
  • Oncology 164
  • Pulmonary and Respiratory Medicine 150
  • Immunology 140
Replace Chunmei Guo with:
Chunmei Guo China
Fei Yang China
Sophie Doublier Italy
Frank Staedtler Switzerland
Jianhua Zhu China
Mingjie Wang China
Minghui Zhao China
Jian Pan China
Recep Bayraktar United States
Ruiqi Wang relative to Chunmei Guo China Chunmei Guo's profile →
Citations per field
00.5×1.5×2.0×
Chunmei Guo · 1×
Citations per year

Countries citing papers authored by Ruiqi Wang

Since Specialization
Citations

This map shows the geographic impact of Ruiqi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruiqi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruiqi Wang more than expected).

Fields of papers citing papers by Ruiqi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruiqi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruiqi Wang. The network helps show where Ruiqi Wang may publish in the future.

Co-authorship network of co-authors of Ruiqi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ruiqi Wang. A scholar is included among the top collaborators of Ruiqi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruiqi Wang. Ruiqi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 2
4 2
5 2
6 1
7 3
8 1
9 0
10 1
11 8
12 1
13 2
14 1
15 5
16 40
17 37
18 2
19 20
20 14

About Ruiqi Wang

Ruiqi Wang is a scholar working on Immunology and Allergy, Cancer Research and Molecular Biology, having authored 115 papers that have together received 1.6k indexed citations. Recurring topics across this work include Allergic Rhinitis and Sensitization (11 papers), RNA modifications and cancer (10 papers) and Cancer-related molecular mechanisms research (9 papers). The work is most often cited by research in Cancer Research (553 citations), Molecular Biology (920 citations) and Immunology and Allergy (47 citations). Ruiqi Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include He Chen, Huilian Hou, Xu Li, Jingjing Pan, Wei Chen, Xiang Wang, Xiang An, Hongli An, Mei Xue and Huan Pang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Agricultural and Food Chemistry and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026